Diethyl 2-(1,3-dioxoisoindolin-2-yl)malonate, 95+%, 1g

N-Carboxyethylrhodanine, 95.0%, 25g

5-(naphthalen-2-yl)-1H-pyrazole-4-carboxylic acid, 95.0%, 1g

{[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]methyl}amine hydrochloride, 95.0%, 100mg

Ethyl 7-bromoquinoline-2-carboxylate, 97%, 100mg

(5-Methyl-4-phenyl-thiazol-2-yl)-hydrazine, 97%, 1g

3-Hydroxy-4-methylbenzoic Acid>98.0%(GC)(T)25g

1-Propanesulfonic acid, 3-[(4'-amino-3,3',5,5'-tetramethyl[1,1'-biphenyl]-4-yl)amino]-, 5g

3-(1H-Indol-3-yl)-propionic acid methyl ester, 95.0%, 5g

3-((3-(N-Cyclopropylsulfamoyl)-7-(2,4-dimethoxypyrimidin-5-yl)quinolin-4-yl)amino)-5-(3,5-difluorophenoxy)benzoic acid, 98%, 250mg

N-(Cyclopropylmethyl)-N-methylamine, 97.0%, 100mg

Infinity corrected plan PL S40x/0.65 IOS objective. Working distance 0.36 mm

5-(2-Phenyleth-1-ynyl)thiophene-2-carbaldehyde, 95.0%, 250mg